糖尿病病,生物标志物,以及精细
Ashish Verma1, Ashish Upadhyay1
1Section of Nephrology, Department of Medicine, Boston Medical Center and Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Diabetes, obesity & metabolism
|January 20, 2026
概括
尽管采用标准治疗方法,糖尿病病 (DKD) 和心血管疾病 (CVD) 的风险仍然存在. 芬龙是一种新型矿物质皮质类受体对手,有效降低DKD患者的脏和心血管疾病风险.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病病 (DKD) 是导致衰竭的主要原因,并增加心血管疾病 (CVD) 的风险.
- 由失调驱动的炎症和纤维化通路,有助于DKD和心血管疾病的进展.
- 目前的治疗方法,如RAAS抑制剂和SGLT2抑制剂,留下了显著的残留风险.
研究的目的:
- 审查DKD和矿物质皮质体受体激活的病变发生.
- 总结芬在DKD治疗中的作用,包括其有效性和安全性.
- 为了评估DKD和finerenone的影响的生物标志物,指导精准医学.
主要方法:
- 对DKD,矿物质皮质类受体抗剂和临床试验的现有文献的审查.
- 对针对炎症和纤维化的费内伦的作用机制的分析.
- 在DKD管理中评估当前和新兴的生物标志物.
主要成果:
- 非类固醇MRA的Finerenone针对关键的DKD通路,并且具有良好的安全性.
- 第三阶段试验表明,当添加到RAAS阻断剂时,芬瑞龙可以减少主要的脏和心血管疾病的结果.
- 菲内伦已被批准并推用于DKD,提供了一种新的治疗选择.
结论:
- 菲内伦代表了DKD治疗的重大进步,解决了残留风险.
- 生物标志物集成对于早期检测和个性化治疗策略至关重要.
- 未来的研究应该集中在生物标志物驱动的精密医学上,以优化DKD患者的护理.
更多相关视频
07:01Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
1.9K
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
3.2K
相关概念视频
01:25Chronic Kidney Disease I: Introduction
590
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
590
01:24Chronic Kidney Disease II: Clinical Manifestations
572
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
572
01:28Chronic Kidney Disease III: Interprofessional Care
356
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
356
01:18Chronic Kidney Disease IV: Nursing Management
328
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
328
01:45Kidney Structure
75.0K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
75.0K
01:20Pathophysiology of Diabetes
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.2K